13.07.2015 Views

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong><strong>Chemical</strong> Stockpile Emergency Preparedness Program role,766demilitarization <strong>of</strong> chemical agents and, 142, 143levels <strong>of</strong> protection, 580waste water disposal issues, 546US Food and Drug Administration“animal rule” for drug product approval, 647, 651anticholinesterase treatment for Alzheimer’s disease, 158clinical trial phases, 647investigational new drug submissions, 649, 650Laboratory Response Network and, 765–766medical chemical defense acquisition programs and, 646, 647,648–653“<strong>of</strong>f-label” uses for drugs, 650phosgene inhalation treatment guidelines, 354Project BioShield and, 251pyridostigmine bromide approval, 204Reactive Skin Decontamination Lotion approval, 536US General Accounting OfficeCBRNE training programs and, 768US Joint Forces Commanddomestic preparedness role, 764US Marine Corpschemical/biological incident response force, 762–763field management <strong>of</strong> chemical casualties, 489–490Joint Non-lethal Weapons Directorate, 431M20 simplified collective protection equipment and, 587US Navybinary weapon research, 123field management <strong>of</strong> chemical casualties, 489, 491–492hospital ships, 491–492US Office <strong>of</strong> Management and BudgetProject BioShield funding, 251US Postal Serviceoleoresin capsicum use, 443US War Department. See also US Department <strong>of</strong> Defensechemical warfare plan, 22chemical weapon stockpiles and, 44gas warfare function centralization, 22Memorandum on Gas Poisoning in <strong>Warfare</strong> with Notes on itsPathology and Treatment, 90Notes on Gas as a Weapon in Modern War, 90USACHPPM. See US Army Center for Health Promotion andPrevention MedicineUSAMRICD. See US Army <strong>Medical</strong> Research Institute <strong>of</strong> <strong>Chemical</strong>DefenseUSAMRIID. See US Army <strong>Medical</strong> Institute <strong>of</strong> Infectious DiseaseUSNS Comforthospital ship capability, 491USNS Mercyhospital ship capability, 491USS Bon Homme Richardhospital ship capability, 491USS Kearsagehospital ship capability, 491VV-series nerve agents. See also specific agentscategorization <strong>of</strong> (exhibit), 47production during the 1950s, 55weaponization <strong>of</strong>, 3VAC. See Vacuum-assisted closure therapyVacuum-assisted closure therapycontraindications to, 287mustard agent injuries, 287van Galen, Christoph Bernharduse <strong>of</strong> toxic smoke projectiles, 11Van Hooidonk, C.decontamination research, 534, 536Vanderbelt, J.M.cyanide poisoning research, 396Vedder, Lt. Col. Edwardcareer <strong>of</strong> (exhibit), 103chemical training for soldiers and, 103comments on Shryock, 108<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>, 1041-chloroacetophenone research, 462Veephysostigmine isolation, 46Ventilatory supportarrhythmias and, 190atropine and, 181, 186, 193hydrogen cyanide inhalation, 354incapacitating agent exposure and, 471–472intermediate syndrome, 318mass casualty incidents, 181, 519–520mechanical devices for, 181mouth-to-mouth ventilation, 181, 675mustard agent injuries, 288–289, 672nerve agent exposure treatment, 181–182, 520triage issues, 519–520Vesicants. See also Incapacitating agents; Lewisite; Mustard agent;Phosgene oximechemical, physical, environmental, and biological properties <strong>of</strong>vesicating agents (table), 260–261conventional wounds contaminated with, 523description, 260, 667management <strong>of</strong> vesicant exposures (table), 671pediatric population and, 667–673prolonged morbidity from, 667triage considerations, 519, 521–522, 523types <strong>of</strong>, 260–261Veterans Administrationphosgene exposure research, 325–326study on the effects <strong>of</strong> mustard agent and lewisite exposure,312–313Viala, B.2-chlorobenzylidene malononitrile research, 471Vietnam WarAgent Orange use, 341defoliant use, 105mustard agent use, 57tear gas use for clearing tunnels, 1052-chlorobenzylidene malononitrile use, 444Vinci, Leonardo dapoison projectile proposal, 11Vision. See EyesVolunteersanticholinergic deliriant testing on, 424–425effects <strong>of</strong> soman on acetylcholinesterase activity in wholeblood from human volunteers who had taken pyridostigminebromide (figure), 706effects <strong>of</strong> soman on acetylcholinesterase activity in wholeblood from human volunteers who were given an increasingdose <strong>of</strong> huperzine A (figure), 707medical research on human volunteers during the 1950s, 551-chloroacetophenone testing on, 461von Deimling, Gen.chemical warfare comments, 15–16von der Linde, Hans-Jürgensarin research, 47, 156von Krueger, Gerdeorganophosphorus compound research, 47von Tappen, Hanslxvi

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!